| Literature DB >> 35758277 |
Chunchun Wu1, Rongsheng Bu1, Yaoguo Wang1, Chaoxiang Xu1, Youfang Chen2, Lishuang Che1, Shengnan Wang1.
Abstract
BACKGROUND AND HYPOTHESIS: The rehabilitation effect of circuit resistance training in coronary heart disease (CHD) patients remains unclear. We perform this review to examine the rehabilitation effect of circuit resistance training in CHD patients and to provide a basis for the formulation of reasonable individual exercise prescriptions for CHD patients.Entities:
Keywords: aerobic training; circuit resistance training; coronary heart disease; meta-analysis; peak oxygen uptake; randomized controlled trial
Mesh:
Year: 2022 PMID: 35758277 PMCID: PMC9346966 DOI: 10.1002/clc.23855
Source DB: PubMed Journal: Clin Cardiol ISSN: 0160-9289 Impact factor: 3.287
Figure 1PRISMA flow chart of literature identifying
Characteristics of studies
| Study | Year | Country | Age (years) | Sex ratio (male%) | Circuit resistance training( | Aerobic training( | Outcomes | Duration (months) | Frequency (times per week) | Dropouts ( | Adverse events | Beta‐blockers use (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theodorou | 2016 | Greece | AT:age = 61 ± 7; CT:age = 64 ± 6 | 100 | 15 | 15 | ②③④⑤ | 8 | 3 | 0 | 0 | NA |
| Santa‐Clara | 2003 | Portugal | AT:age = 57 ± 11; CT:age = 55 ± 10 | 100 | 13 | 13 | ②③ | 12 | 3 | 0 | 0 | NA |
| Vona | 2009 | Switzerland | AT:age = 56 ± 6; CT:age = 55 ± 9 | 75.5 | 53 | 52 | ①②④⑤⑥ | 1 | 4 | 0 | 0 | NA |
| Hansen | 2011 | Belgium | AT:age = 58.9 ± 7.2; CT:age = 60.4 ± 8.9 | 95 | 22 | 25 | ①④⑤ | 1.6 | 3 | 13 | 1 | 72.3 |
| Tofas | 2021 | Greece | AT:age = 61 ± 7; CT:age = 64 ± 6 | NA | 15 | 15 | ⑥ | 8 | 3 | 0 | 0 | NA |
| Marzolini‐1 | 2008 | Canada | AT:age = 57.9 ± 2.6; CT:age = 60.9 ± 2.3 | 11.3 | 18 | 14 | ① | 6 | 5 | 13 | 4 | 83 |
| Marzolini‐2 | 2008 | Canada | AT:age = 57.9 ± 2.6; CT:age = 62.7 ± 2.7 | 11.3 | 18 | 14 | ① | 6 | 5 | 13 | 4 | 83 |
| Santa‐Clara | 2002 | Portugal | AT:age = 57 ± 11; CT:age = 55 ± 10 | 100 | 14 | 14 | ① | 12 | 3 | 0 | 0 | 50 |
| Gayda | 2009 | France | AT:age = 55 ± 8; CT:age = 55 ± 8 | 100 | 8 | 8 | ①③ | 1.75 | 3 | 0 | 0 | 68.8 |
| Lepretre | 2016 | France | AT:age = 64.6 ± 9.1; CT:age = 63.1 ± 7.0 | 100 | 16 | 16 | ① | 1 | 5 | 0 | 0 | 100 |
Note: ① VO2 peak; ② BMI; ③ Fat mass (FM, in %); ④ TG; ⑤ CHO; ⑥ SBP; ⑦ AT: aerobic training; ⑧ CT, circuit resistance training; ⑨ NA, Not available.
Standardized outcomes according to training intensity
| Outcomes | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VO2 | BMI | Fat mass | SBP | CHO | TG | Duration | Frequency | Time ratio | |||||||
| Study | Interventional | Control | Interventional | Control | Interventional | Control | Interventional | Control | Interventional | Control | Interventional | Control | (Month) | (times per week) | |
| Theodorou‐1 | NA | NA | 1.2 | 1.3 | 1.4 | 1.4 | NA | NA | 0.2 | 0.2 | 0.1 | 0.1 | 8 | 3 | 24 |
| Theodorou‐2 | NA | NA | 1.2 | 1.3 | 1.3 | 1.3 | NA | NA | 0.2 | 0.2 | 0.0 | 0.0 | 8 | 3 | 24 |
| Santa‐Clara | NA | NA | 0.7 | 0.8 | 0.7 | 0.9 | NA | NA | NA | NA | NA | NA | 12 | 3 | 36 |
| Vona | 6.6 | 6.4 | 6.5 | 6.8 | 0.0 | 0.0 | 46.5 | 45.5 | 39.5 | 40.8 | 37.8 | 38.5 | 1 | 4 | 4 |
| Hansen | 424.6 | 435.2 | NA | NA | NA | NA | NA | NA | 29.0 | 29.8 | 21.0 | 24.4 | 1.6 | 3 | 4.8 |
| Tofas‐1 | NA | NA | NA | NA | NA | NA | 5.4 | 5.3 | NA | NA | NA | NA | 8 | 3 | 24 |
| Tofas‐2 | NA | NA | NA | NA | NA | NA | 5.1 | 5.3 | NA | NA | NA | NA | 8 | 3 | 24 |
| Marzolini ‐1 | 0.8 | 0.8 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 6 | 5 | 30 |
| Marzolini ‐2 | 0.7 | 0.8 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 6 | 5 | 30 |
| Santa‐Clara | 1.2 | 0.9 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 12 | 3 | 36 |
| Gayda | 5.9 | 4.6 | NA | NA | 5.3 | 5.7 | NA | NA | NA | NA | NA | NA | 1.75 | 3 | 5.25 |
| Lepretre | 3.5 | 3.2 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 1 | 5 | 5 |
Note: ① VO2 Peak: maximum oxygen flow per minute; ② BMI: body mass index (kg/m2); ③ SBP: systolic blood pressure; ④ CHO: cholesterol; ⑤ TG: triglyceride; ⑥ NA: not available; ⑦ Time value: the absolute value/(duration*frequency).
Figure 2Risk bias summary
Figure 3Risk biases of each study
Figure 4Forest plots of each outcome measure: (A), the VO2 peak; (b), the BMI; (C), the Fat mass (FM, in %); (D), the SBP; (E), the CHO; and (F), the TG. Block size is an inverse function of accuracy. BMI, body mass index; CHO, cholesterol; TG, triglyceride.